TRAUMON

This brand name is authorized in Austria, Germany, Malta, Poland

Active ingredients

The drug TRAUMON contains one active pharmaceutical ingredient (API):

1 Etofenamate UNII KZF0XM66JC - ETOFENAMATE

Etofenamate is a flufenamic acid derivative, which is readily transported through the skin and concentrated in inflamed tissue, where it exerts anti-inflammatory and analgesic effects by inhibiting the release of histamine, lysosomal enzymes and prostaglandin. Read about Etofenamate

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TRAUMON Gel	Medicines Authority (MT)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M02AA06	Etofenamate	M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use
Discover more medicines within M02AA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 02591488, 02792821, 03935211, 04971953
Country: MT	Medicines Authority	Identifier(s): MA1507/02301
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100078690, 100078708